Elsevier

Virus Research

Volume 47, Issue 1, January 1997, Pages 85-90
Virus Research

Short communication
Polyomavirus large T-antigen binds the ‘pRb related’ protein p130 through sequences in conserved region 2

https://doi.org/10.1016/S0168-1702(96)01404-9Get rights and content

Abstract

The transforming potential of DNA tumor viruses derives mainly from the ability of their encoded oncogene products to interact with cellular proteins. Many of these viral oncoproteins share regions of sequence similarity, designated conserved region 1 and 2, which have been implicated in complex formation with pRb, the product of the retinoblastoma tumor suppressor gene, and related p107 and p130 species. It has now been shown that the E1A protein of adenovirus is able to bind to all three pRb-related proteins through sequences in conserved region 1 and 2. We have shown previously that polyomavirus large T-antigen also interacts with pRb and p107 in vitro. The pRb and p107 binding domains reside between residues 141–158, which include conserved region 2. In the present study, we demonstrate that polyomavirus large T-antigen also interacted with p130 in vitro through the same sequences in conserved region 2.

References (37)

  • L.R. Bandara et al.

    Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTFI/E2F

    EMBO J.

    (1993)
  • D. Barbeau et al.

    Functional interactions within adenovirus E1A protein complexes

    Oncogene

    (1994)
  • L. Cao et al.

    Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F

    Nature

    (1992)
  • P.P. Claudio et al.

    p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107

    Cancer Res.

    (1994)
  • D. Cobrinik et al.

    Cell cycle-specific association of E2F with the p130 E1A-binding protein

    Genes Dev.

    (1993)
  • N. Dyson et al.

    Large T-antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein

    J. Virol.

    (1990)
  • N. Dyson et al.

    The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

    Science

    (1989)
  • C. Edmonds et al.

    A point mutational analysis of human papillomavirus type 16 E7 protein

    J. Virol.

    (1989)
  • Cited by (7)

    • Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin’s lymphomas: Implications for disease pathogenesis

      2002, Human Pathology
      Citation Excerpt :

      Although such a pattern of RB2/p130 and p107 expression has been found in other types of NHL,10,15 this was not the case in the present series of AIDS-related lymphomas. The absence of mutations in the RB2/p130 gene and the unusually high percentages of cells expressing pRb2/p130 in tumors with a high proliferative activity, such as AIDS-related lymphomas, may thus suggest a molecular mechanism similar to that observed in virus-linked oncogenesis.32-34 The results of our in vitro and in vivo binding assays indicate that Tat protein of HIV-1 is a viral protein that may physically interact with pRb2/p130.

    • Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes

      2000, American Journal of Pathology
      Citation Excerpt :

      Yet, a significant portion of E2F4 can exist as free E2F42 and/or can be bound to an as yet unidentified protein,43 thus driving cells to proliferation. In AIDS-related BL, the absence of mutations in the RB2/p130 gene and the unusually high levels of nuclear expression of both pRb2/p130 and p107 suggest that other mechanisms similar to the one observed in the virus-linked oncogenesis could be involved.44,45,47 All members of the retinoblastoma gene family share the ability to physically interact with certain oncoproteins of the DNA viruses.46

    • Study on JV virus in patients with colon cancer type adenocarcinoma

      2019, Asian Pacific Journal of Cancer Prevention
    View all citing articles on Scopus
    View full text